Cellular homeostasis depends critically on the controlled degradation of proteins. Cells employ an intricate waste-disposal system to ensure that obsolete or harmful proteins are tagged for destruction and subsequently dismantled by specialized enzymes. Exploiting this natural process, molecular glues function by bridging proteins that do not normally interact, guiding harmful proteins toward degradation pathways. This elegant strategy offers an unprecedented level of selectivity and therapeutic potential, particularly for proteins that evade conventional drug targeting.

Historically, the identification of molecular glues has been serendipitous, limiting efficient exploitation across diverse therapeutic landscapes. Addressing this, a team led by Georg Winter, Scientific Director at the AITHYRA Research Institute and Adjunct Principal Investigator at CeMM in Vienna, alongside Michael Erb from the Scripps Research Institute, developed an innovative high-throughput chemical diversification technique paired with live-cell functional screening. This approach enables the rapid exploration of vast chemical modifications on an initial small molecule scaffold, uncovering variants that effectively reshape protein surfaces to foster new protein-protein interactions.

This methodology involves synthesizing thousands of molecular variants by systematically appending diverse chemical building blocks to a known protein ligand. Each variant subtly alters the ligand’s interface, potentially fostering novel contacts between the target protein and cellular degradation enzymes. Crucially, the screening is conducted in live cells without prior compound purification, using sensitive assays that report real-time degradation of the protein target. This fusion of chemical synthesis and cellular biology allows researchers to pinpoint active compounds with genuine biological efficacy from enormous chemical spaces in a highly efficient manner.

The researchers applied this cutting-edge approach to the leukemia-associated protein ENL, a critical regulator in certain aggressive forms of acute leukemia. Screening thousands of ligand derivatives led to identifying a compound that selectively induces robust degradation of ENL in leukemia cells. Subsequent investigations demonstrated that this compound reprograms the protein’s interaction landscape, promoting recruitment of a ubiquitin ligase complex responsible for tagging ENL with ubiquitin molecules, effectively marking it for destruction by the proteasome.

Fundamental to the activity of these compounds is their cooperative binding mechanism, a hallmark of molecular glues. Rather than indiscriminately binding to both partners, the molecule binds the target protein first, then facilitates a new interface that recruits the enzymatic degradation machinery. This mechanism underpins both the specificity and efficacy of the induced protein degradation, minimizing off-target effects and enhancing therapeutic potential.

The successful targeted degradation of ENL elucidates the enormous promise held by molecular glue technology. By precisely ablating proteins driving leukemia progression, this approach curtails malignant cell growth and opens pathways for new leukemia treatments with potentially fewer side effects compared to current therapies. Moreover, the demonstration that high-throughput ligand diversification and functional screening can yield such potent glues paves the way for broad applications across a spectrum of diseases.

The implications of this work extend far beyond ENL and leukemia. The generalizable workflow combining scalable chemical innovation with phenotype-based cellular screening transforms the paradigm of proximity-inducing drug discovery. Where once the hunt for molecular glues was slow and hit-or-miss, it can now be approached rationally with vast chemical libraries tested directly in biological contexts, accelerating the translation from molecule to medicine.

Georg Winter emphasizes that this breakthrough sets the foundation for a new era in drug design, making it feasible to target proteins, once deemed ‘undruggable,’ with small molecules that enlist the cell’s own degradation machinery for therapeutic benefit. This extends the druggable proteome dramatically, enabling intervention in diseases where pathogenic proteins have historically eluded pharmacological control.

Furthermore, the integration of artificial intelligence and next-generation automated chemistry platforms at institutions like AITHYRA will likely amplify this approach’s efficiency and breadth. The convergence of AI-driven design, robotic synthesis, and live-cell functional assays creates a powerful ecosystem to systematically identify molecular glues tailored to diverse therapeutic targets, accelerating drug discovery timelines significantly.

As molecular glues gain traction in both academic and pharmaceutical sectors, the strategy heralded by this study could revolutionize how diseases such as cancer, neurodegeneration, and viral infections are treated. Through rational, scalable ligand diversification paired with cell-based functional screening, there is newfound optimism that targeted protein degradation can become a mainstay of precision medicine, offering customized therapies with high specificity and minimal side effects.

This landmark study, published in Nature Chemical Biology, underscores the transformative potential of combining high-throughput chemistry with live-cell biology to unlock new drug modalities. The systematic discovery of molecular glues not only represents a technical tour de force but also a conceptual leap forward, fostering a deeper understanding of protein interactions and cellular degradation pathways that can be leveraged for therapeutic innovation.

The impact of these findings is already resonating through the scientific community, evoking excitement about the possibilities molecular glues hold for treating a vast array of diseases. As this platform matures, it promises to illuminate previously dark corners of the proteome, making the impossible task of targeting elusive proteins a tangible reality.

Subject of Research: Cells

Article Title: High-throughput ligand diversification to discover chemical inducers of proximity

News Publication Date: February 16, 2026

Web References:
https://doi.org/10.1038/s41589-025-02137-2

References:
Shaum JB, Muñoz i Ordoño M, Steen EA, et al. High-throughput ligand diversification to discover chemical inducers of proximity. Nature Chemical Biology. 2026; DOI:10.1038/s41589-025-02137-2.

Image Credits: © Miquel Muñoz

Keywords: Leukemia, Proteins, Molecular glues, Targeted protein degradation, High-throughput screening, Chemical biology, Drug discovery, Acute leukemia, Ubiquitin ligase, ENL protein

Viruses are traditionally viewed as simple entities dependent on hijacking their host’s cellular systems to propagate. However, the discovery of giant viruses, some rivaling small bacteria in size and genetic complexity, has challenged this paradigm. Unlike typical viruses, giant viruses possess expansive genomes encoding numerous functions, blurring lines between viral and cellular life forms. This latest research elucidates how one of these colossal viruses creates an isolated and optimized microenvironment inside an amoeba cell to streamline the process of translating viral RNA into functional proteins.

The study employed state-of-the-art imaging techniques combined with molecular analyses to visualize and characterize this subcellular niche formed during infection. Using high-resolution electron microscopy and fluorescence microscopy, the researchers demonstrated that the virus does not simply infiltrate the host cytoplasm. Instead, it induces the assembly of a defined compartment reminiscent of cellular organelles, packed with ribosomes, viral mRNA, and accessory factors necessary for protein synthesis. This compartment acts as a viral translation factory, segregating viral processes from the host cytoplasmic milieu.

Such compartmentalization is remarkable because it allows the virus to commandeer translation machinery with unprecedented efficiency and possibly evade host antiviral defenses. By spatially concentrating the components required for viral protein production, the virus minimizes competition with host mRNAs and regulatory elements. This microenvironment likely enhances the speed and capacity of viral gene expression, crucial for the rapid propagation of viral progeny.

Molecular dissection of the viral genome revealed that it encodes not only structural proteins and enzymes but also factors directly involved in modulating host translation. These include viral homologs of translation initiation factors and proteins that remodel host ribosomes to preferentially translate viral transcripts. This discovery suggests an evolved viral strategy that goes beyond mere hijacking — it actively engineers the translation machinery to optimize the synthesis of its own proteins, adapting the environment within the host cell.

Intriguingly, the research also unveiled that the virus-induced compartment forms through the remodeling of host membranes and cytoskeletal elements. This dynamic reorganization produces a semi-isolated niche that selectively incorporates viral and host components favorable to translation. The findings blur the distinction between viral factories and organelles, highlighting the virus’s capacity to reprogram cellular architecture to meet its biological needs.

The identification of this viral translation factory has profound implications for our understanding of virus-host interactions. It underscores the complexity of the molecular arms race where viruses evolve elaborate mechanisms to subvert cellular defenses and optimize replication. Such specialized compartments could contribute to viral fitness by preventing host antiviral signaling pathways from accessing viral RNA or proteins, thereby enhancing infection success.

This discovery has also provided insights into the evolutionary biology of giant viruses and their relationships with amoebae and potentially other hosts. The elaborate subcellular niche reflects a long co-evolutionary history, indicating that these viruses have developed intricate strategies to integrate their life cycles intimately with host cell biology. These mechanisms may explain the persistence and ecological impact of giant viruses in diverse environments.

Furthermore, the studies raise important questions about the universality of such viral translation compartments. Are they unique to this particular giant virus and host system, or might similar structures exist across broader viral taxa? Understanding the molecular determinants and structural dynamics of this compartment may reveal conserved principles that could be leveraged for antiviral drug development or synthetic biology applications.

From a methodological perspective, this research showcases the power of combined advanced imaging, molecular biology, and virology techniques. By visualizing viral replication at nanometer resolution and correlating this with functional biochemical assays, researchers have painted a holistic picture of viral translation modulation. This integrative approach sets a benchmark for studying complex virus-host encounters in cellular contexts.

The scientific community anticipates that these findings will catalyze further explorations into subcellular viral architectures and their roles in infection biology. The discovery that a virus can construct a translation-optimized environment within a host cell challenges classical models of viral replication and opens avenues for discovering novel therapeutic targets, especially in combating viruses with large genomes capable of manipulating cellular machinery to such an extent.

In conclusion, the revelation that a giant virus engineers a specialized subcellular environment dedicated to viral mRNA translation within an amoeba host marks a paradigm shift in our understanding of viral replication strategies. This sophisticated mechanism exemplifies viral ingenuity and evolution, illustrating how viruses can go beyond hijacking and actively remodel host cellular organization for their benefit. The continuing exploration of such phenomena promises to deepen our knowledge of virus biology and may inform new strategies to intervene in viral diseases.

Subject of Research: Giant virus-induced specialized subcellular environment facilitating efficient translation within an amoeba host

Article Title: A giant virus forms a specialized subcellular environment within its amoeba host for efficient translation

Article References:
Zhang, R., Mayer, L., Hikida, H. et al. A giant virus forms a specialized subcellular environment within its amoeba host for efficient translation. Nat Microbiol (2026). https://doi.org/10.1038/s41564-025-02234-x

DOI: https://doi.org/10.1038/s41564-025-02234-x

Image Credits: AI Generated